Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PNU-282987 is a selective α7 nicotinic acetylcholine receptor(α7 nAChR) agonist with Ki of 26 nM; no affinity for α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 41.00 | |
10 mg | In stock | $ 65.00 | |
25 mg | In stock | $ 133.00 | |
50 mg | In stock | $ 239.00 | |
100 mg | In stock | $ 439.00 | |
200 mg | In stock | $ 585.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 71.00 |
Description | PNU-282987 is a selective α7 nicotinic acetylcholine receptor(α7 nAChR) agonist with Ki of 26 nM; no affinity for α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM). |
Targets&IC50 | α7 nAChR (rat):26 nM(Ki) |
Kinase Assay | Kinase inhibition assays : Kinase inhibition is measured by the use of radiometric assays conducted by Kinase Profiler service. Briefly, in the presence or absence of SKLB1002, VGFR2 (5–10 mU) is incubated in 25-μL reaction solution containing 8 mmol/L 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7.0, 0.2 mmol/L EDTA, 0.33 mg/mL myelin basic protein, 10 mmol/L Mg acetate, and γ-[33P]ATP. After incubation for 40 minutes at room temperature, the reaction is stopped and 10 μL of the reaction solution is then spotted onto a P30 filtermat and washed 3 times for 5 minutes in 75 mmol/L phosphoric acid and once in methanol prior to scintillation counting. |
Molecular Weight | 301.21 |
Formula | C14H18Cl2N2O |
CAS No. | 123464-89-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 26.5 mg/mL(100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PNU-282987 123464-89-1 Neuroscience AChR nAChR Inhibitor PNU282987 Nicotinic acetylcholine receptors inhibit PNU 282987 inhibitor